gemigliptin,
LC15-0444,
Gemigliptin,
911637-19-9,
UNII-5DHU18M5D6,
LC15-0444,
5DHU18M5D6,
(S)-1-(2-Amino-4-(2,4-bis(trifluoromethyl)-5,6-dihydropyrido[3,4-d]pyrimidin-7(8H)-yl)-4-oxobutyl)-5,5-difluoropiperidin-2-one,
(S)-1-(2-amino-4-(2,4-bis(trifluoromethyl)-5,8-dihydropyrido[3,4-d]pyrimidin-7(6H)-yl)-4-oxobutyl)-5,5-difluoropiperidin-2-one,
Gemigliptin [INN],
Gemigliptin (prop.INN),
SCHEMBL1262740,
CHEMBL3707235,
CHEBI:134731,
ZINC68245464,
AKOS025290873,
API0013914,
DB12412,
PB11419,
2-Piperidinone, 1-((2S)-2-amino-4-(5,8-dihydro-2,4-bis(trifluoromethyl)pyrido(3,4-d)pyrimidin-7(6H)-yl)-4-oxobutyl)-5,5-difluoro-,
AK170799,
HY-14892,
Pyrido(3,4-d)pyrimidine, 7-((3S)-3-amino-4-(5,5-difluoro-2-oxo-1-piperidinyl)-1-oxobutyl)-5,6,7,8-tetrahydro-2,4-bis(trifluoromethyl)-,
CS-0003618,
LC-15-0444,
D10502,
1-((2S)-2-Amino-4-(2,4-bis(trifluoromethyl)-5,8-dihydropyrido(3,4-d)pyrimidin-7(6H)-yl)-4-oxobutyl-5,5-difluoropiperidin-2-one,
zemiglo,
D0ZD3C,
CID11953153,
CID 11953153,